These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 7349690)
1. [Indications for sulfones in dermatology (excluding leprosy). Experience of the dermatological clinic in Strasbourg]. Samsoen M; Bousquet F; Basset A LARC Med; 1981 Dec; 1(3):63-4. PubMed ID: 7349690 [No Abstract] [Full Text] [Related]
2. [Our experience with dapsone in dermatology]. Rollier R LARC Med; 1981 Dec; 1(3):65-6. PubMed ID: 7349691 [No Abstract] [Full Text] [Related]
3. Dapsone and sulfones in dermatology: overview and update. Zhu YI; Stiller MJ J Am Acad Dermatol; 2001 Sep; 45(3):420-34. PubMed ID: 11511841 [TBL] [Abstract][Full Text] [Related]
4. Innovative use of dapsone. Wozel VE Dermatol Clin; 2010 Jul; 28(3):599-610. PubMed ID: 20510768 [TBL] [Abstract][Full Text] [Related]
5. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone. Sapkota BR; Shrestha K; Pandey B; Walker SL Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989 [TBL] [Abstract][Full Text] [Related]
6. [Dapsone in skin diseases]. Zalewska A; Napieralska-Krzysiek E Pol Merkur Lekarski; 2003 Nov; 15(89):484-6. PubMed ID: 14969150 [TBL] [Abstract][Full Text] [Related]
7. Dapsone-induced methemoglobinemia in leprosy patients. Kaur I; Mehta M; Agnihotri N; Dogra S; Ganguly NK Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):247-9. PubMed ID: 11875770 [No Abstract] [Full Text] [Related]
8. The response of generalized granuloma annulare to dapsone. Czarnecki DB; Gin D Acta Derm Venereol; 1986; 66(1):82-4. PubMed ID: 2424227 [TBL] [Abstract][Full Text] [Related]
9. Incidence of anemia in leprosy patients treated with dapsone. Puavilai S; Chutha S; Polnikorn N; Timpatanapong P; Tasanapradit P; Charuwichitratana S; Boonthanom A; Wongwaisayawan H J Med Assoc Thai; 1984 Jul; 67(7):404-7. PubMed ID: 6512448 [No Abstract] [Full Text] [Related]
10. Dapsone haemolysis in leprosy. A preliminary report. Menezes S; Rege VL; Sehgal VN Lepr India; 1981 Jan; 53(1):63-9. PubMed ID: 7218764 [TBL] [Abstract][Full Text] [Related]
11. Treatment of generalized granuloma annulare with dapsone. Saied N; Schwartz RA; Estes SA Arch Dermatol; 1980 Dec; 116(12):1345-6. PubMed ID: 7458358 [No Abstract] [Full Text] [Related]
12. The neurotoxicity of dapsone. Daneshmend TK Adverse Drug React Acute Poisoning Rev; 1984; 3(1):43-58. PubMed ID: 6091422 [No Abstract] [Full Text] [Related]
14. Sulfonamides and sulfones in dermatologic therapy. Bernstein JE; Lorincz AL Int J Dermatol; 1981 Mar; 20(2):81-8. PubMed ID: 7012050 [No Abstract] [Full Text] [Related]
15. Dapsone and sulfones in dermatology: overview and update. Pfeiffer C; Wozel G J Am Acad Dermatol; 2003 Feb; 48(2):308-9. PubMed ID: 12582416 [No Abstract] [Full Text] [Related]
16. Malaria, leprosy and dapsone. Saha K; Kapoor L; Arora VM; Chattopadhya D Southeast Asian J Trop Med Public Health; 2003 Sep; 34(3):501-4. PubMed ID: 15115119 [TBL] [Abstract][Full Text] [Related]
17. The story of sulfones in tropical medicine and dermatology. Wozel G Int J Dermatol; 1989; 28(1):17-21. PubMed ID: 2645226 [No Abstract] [Full Text] [Related]
18. Twenty five years follow up of MB leprosy patients retreated with a modified MDT regimen after a full course of dapsone mono-therapy. Jing Z; Zhang R; Zhou D; Chen J Lepr Rev; 2009 Jun; 80(2):170-6. PubMed ID: 19743621 [TBL] [Abstract][Full Text] [Related]